![Camilla Sylvest](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Camilla Sylvest
Directeur/Membre du Conseil chez
ARGENX SE
Fortune : 2 M $ au 31/05/2026
Profil
Camilla Sylvest is currently an Independent Non-Executive Director at argenx SE since 2022.
Ms. Sylvest is also a Director at Zealand Pharma A and Getinge AB, both positions starting in 2026.
Former roles include Vice Chairman at World Diabetes Foundation, Independent Director at Danish Crown A, Senior Vice President & General Manager-Germany at Novo Nordisk Pharma GmbH, and EVP-Commercial Strategy & Corporate Affairs at Novo Nordisk A from 2017 to 2025.
Education includes a graduate degree from the University of Southern Denmark in 1998 and an MBA from Scandinavian International Management Institute in 2003.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARGENX SE 0 % | 19/02/2026 | 1 871 ( 0 % ) | 2 M $ | 31/05/2026 |
Postes actifs de Camilla Sylvest
| Sociétés | Poste | Début |
|---|---|---|
| ARGENX SE | Directeur/Membre du Conseil | 08/09/2022 |
| GETINGE AB | Directeur/Membre du Conseil | 21/04/2026 |
| ZEALAND PHARMA A/S | Directeur/Membre du Conseil | 26/05/2026 |
Anciens postes connus de Camilla Sylvest
| Sociétés | Poste | Fin |
|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | 03/04/2025 |
World Diabetes Foundation
 World Diabetes Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Directeur/Membre du Conseil | - |
Danish Crown A/S
 Danish Crown A/S Food: Meat/Fish/DairyConsumer Non-Durables Engages in processing and sale of chilled & frozen meat products, pork, beef, poultry and lamb | Directeur/Membre du Conseil | - |
Novo Nordisk Pharma GmbH
 Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Corporate Officer/Principal | - |
Formation de Camilla Sylvest
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
58
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Novo Nordisk Pharma GmbH
Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Getinge AB
 Getinge AB Medical SpecialtiesHealth Technology Manufactures and distributes medical devices and disinfectants | Health Technology |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
University of Southern Denmark
 University of Southern Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scandinavian International Management Institute
 Scandinavian International Management Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Danish Crown A/S
Danish Crown A/S Food: Meat/Fish/DairyConsumer Non-Durables Engages in processing and sale of chilled & frozen meat products, pork, beef, poultry and lamb | Consumer Non-Durables |
argenx SE
 argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
World Diabetes Foundation
World Diabetes Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
